Chalice Pharmacies Limited - Accounts to registrar (filleted) - small 18.2

Chalice Pharmacies Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v21.3.0.583 03481415 Board of Directors 1.2.20 31.1.21 31.1.21 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure034814152020-01-31034814152021-01-31034814152020-02-012021-01-31034814152019-01-31034814152019-02-012020-01-31034814152020-01-3103481415ns16:EnglandWales2020-02-012021-01-3103481415ns15:PoundSterling2020-02-012021-01-3103481415ns11:Director12020-02-012021-01-3103481415ns11:PrivateLimitedCompanyLtd2020-02-012021-01-3103481415ns11:SmallEntities2020-02-012021-01-3103481415ns11:AuditExempt-NoAccountantsReport2020-02-012021-01-3103481415ns11:SmallCompaniesRegimeForDirectorsReport2020-02-012021-01-3103481415ns11:SmallCompaniesRegimeForAccounts2020-02-012021-01-3103481415ns11:FullAccounts2020-02-012021-01-310348141512020-02-012021-01-3103481415ns11:Director22020-02-012021-01-3103481415ns11:CompanySecretary12020-02-012021-01-3103481415ns11:RegisteredOffice2020-02-012021-01-3103481415ns6:CurrentFinancialInstruments2021-01-3103481415ns6:CurrentFinancialInstruments2020-01-3103481415ns6:Non-currentFinancialInstruments2021-01-3103481415ns6:Non-currentFinancialInstruments2020-01-3103481415ns6:ShareCapital2021-01-3103481415ns6:ShareCapital2020-01-3103481415ns6:RetainedEarningsAccumulatedLosses2021-01-3103481415ns6:RetainedEarningsAccumulatedLosses2020-01-3103481415ns6:NetGoodwill2020-02-012021-01-3103481415ns6:IntangibleAssetsOtherThanGoodwill2020-02-012021-01-3103481415ns6:LandBuildingsns6:LongLeaseholdAssets2020-02-012021-01-3103481415ns6:FurnitureFittings2020-02-012021-01-3103481415ns6:MotorVehicles2020-02-012021-01-3103481415ns6:NetGoodwill2020-01-3103481415ns6:NetGoodwill2021-01-3103481415ns6:NetGoodwill2020-01-3103481415ns6:LandBuildingsns6:LongLeaseholdAssets2020-01-3103481415ns6:FurnitureFittings2020-01-3103481415ns6:MotorVehicles2020-01-3103481415ns6:LandBuildingsns6:LongLeaseholdAssets2021-01-3103481415ns6:FurnitureFittings2021-01-3103481415ns6:MotorVehicles2021-01-3103481415ns6:LandBuildingsns6:LongLeaseholdAssets2020-01-3103481415ns6:FurnitureFittings2020-01-3103481415ns6:MotorVehicles2020-01-3103481415ns6:CurrentFinancialInstrumentsns6:WithinOneYear2021-01-3103481415ns6:CurrentFinancialInstrumentsns6:WithinOneYear2020-01-3103481415ns6:RetainedEarningsAccumulatedLosses2020-01-3103481415ns6:RetainedEarningsAccumulatedLosses2020-02-012021-01-3103481415ns11:Director112020-01-3103481415ns11:Director112019-01-3103481415ns11:Director112020-02-012021-01-3103481415ns11:Director112019-02-012020-01-3103481415ns11:Director112021-01-3103481415ns11:Director112020-01-31034814152ns11:Director22020-01-31034814152ns11:Director22019-01-31034814152ns11:Director22020-02-012021-01-31034814152ns11:Director22019-02-012020-01-31034814152ns11:Director22021-01-31034814152ns11:Director22020-01-31
REGISTERED NUMBER: 03481415 (England and Wales)




UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2021

FOR

CHALICE PHARMACIES LIMITED

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 January 2021




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CHALICE PHARMACIES LIMITED

COMPANY INFORMATION
for the year ended 31 January 2021







DIRECTORS: M S Mann
B S Atwal





SECRETARY: Mrs B K Mann





REGISTERED OFFICE: 1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB





REGISTERED NUMBER: 03481415 (England and Wales)





ACCOUNTANTS: LDP Luckmans
1110 Elliott Court
Coventry Business Park
Herald Avenue
Coventry
West Midlands
CV5 6UB

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

BALANCE SHEET
31 January 2021

2021 2020
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 1,705,873 1,858,431
Tangible assets 5 344,409 387,404
2,050,282 2,245,835

CURRENT ASSETS
Stocks 178,027 170,902
Debtors 6 864,580 627,853
Cash at bank and in hand 367,518 384,111
1,410,125 1,182,866
CREDITORS
Amounts falling due within one year 7 1,150,820 1,074,524
NET CURRENT ASSETS 259,305 108,342
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,309,587

2,354,177

CREDITORS
Amounts falling due after more than one
year

8

(2,032,446

)

(2,175,870

)

PROVISIONS FOR LIABILITIES (57,433 ) (65,383 )
NET ASSETS 219,708 112,924

CAPITAL AND RESERVES
Called up share capital 240 240
Retained earnings 9 219,468 112,684
SHAREHOLDERS' FUNDS 219,708 112,924

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2021.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2021 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

BALANCE SHEET - continued
31 January 2021


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 October 2021 and were signed on its behalf by:





M S Mann - Director


CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 January 2021

1. STATUTORY INFORMATION

Chalice Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 1997, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Long leasehold - 2% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2021

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 46 (2020 - 45 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 February 2020
and 31 January 2021 3,051,160
AMORTISATION
At 1 February 2020 1,192,729
Amortisation for year 152,558
At 31 January 2021 1,345,287
NET BOOK VALUE
At 31 January 2021 1,705,873
At 31 January 2020 1,858,431

5. TANGIBLE FIXED ASSETS
Fixtures
Long and Motor
leasehold fittings vehicles Totals
£    £    £    £   
COST
At 1 February 2020 57,679 595,795 68,700 722,174
Additions - 17,563 - 17,563
At 31 January 2021 57,679 613,358 68,700 739,737
DEPRECIATION
At 1 February 2020 14,394 303,200 17,176 334,770
Charge for year 1,154 46,522 12,882 60,558
At 31 January 2021 15,548 349,722 30,058 395,328
NET BOOK VALUE
At 31 January 2021 42,131 263,636 38,642 344,409
At 31 January 2020 43,285 292,595 51,524 387,404

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2021

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Trade debtors 706,156 461,392
Other debtors 57,831 58,704
Sundry debtors 3,136 3,044
Directors' current accounts 80,000 84,762
Prepayments 17,457 19,951
864,580 627,853

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2021 2020
£    £   
Bank loans and overdrafts 128,604 130,610
Hire purchase contracts 13,740 13,740
Trade creditors 862,660 869,477
Tax 110,871 28,768
Social security and other taxes 8,523 4,720
Other creditors 1,762 1,498
Accruals and deferred income 499 565
Accrued expenses 24,161 25,146
1,150,820 1,074,524

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2021 2020
£    £   
Bank Loans - More than 1yr 2,001,531 2,131,215
Hire purchase contracts 30,915 44,655
2,032,446 2,175,870

9. RESERVES
Retained
earnings
£   

At 1 February 2020 112,684
Profit for the year 286,784
Dividends (180,000 )
At 31 January 2021 219,468

CHALICE PHARMACIES LIMITED (REGISTERED NUMBER: 03481415)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 January 2021

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 January 2021 and 31 January 2020:

2021 2020
£    £   
M S Mann
Balance outstanding at start of year 63,463 78,463
Amounts repaid (1,463 ) (15,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 62,000 63,463

B S Atwal
Balance outstanding at start of year 21,299 26,299
Amounts repaid (3,299 ) (5,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 18,000 21,299